Business

Meda has announced an expansion in its partnership with Cipla, which is already supplying azelastine for Meda's Dymista nasal spray. With the new agreement, Meda will continue to take responsibility for clinical development and commercialization of Dymista; Cipla will take responsibility for formulation. According to Meda, the company will "now have full coverage in … [Read more...] about Meda and Cipla expand Dymista partnership; Meda denies talk of sale to Sun

Irish biotech company Elan, which recently paid $1 billion to Theravance for royalty payments from sales of Breo (Relvar) Ellipta and other inhaled drugs, has been awarded an injunction against Royalty Pharma by an Irish court. The order restrains Royalty Pharma from distributing a proxy statement to Elan shareholders. Royalty Pharma has been seeking to acquire … [Read more...] about Elan gets injunction against Royalty Pharma

Grifols is paying $25 million upfront, plus up to $25 million in milestone payments to acquire a worldwide license for Aradigm’s Pulmaquin and Lipoquin inhaled ciprofloxacin formulations. Grifols will also pay tiered royalties on worldwide sales of products using the formulations and will be responsible for up to $65 million in expenses for Phase 3 development and … [Read more...] about Grifols licenses Aradigm’s inhaled ciprofloxacin formulations

According to Aegis Therapeutics, the company has been granted US Patent No. 8,440,631 for fast-acting formulations of triptans for the treatment of migraines. The patent is the second for Aegis's triptan nasal sprays using its Intravail transmucosal absorption enhancers; the company got the first patent in September 2012. Clinical trials have demonstrated that … [Read more...] about Aegis gets second patent for intranasal formulations of triptans

The European Patent Office will grant Insmed Incorporated EU Patent No. 1909759 for Arikace liposomal amikacin for inhalation, according to Insmed. The composition of matter patent, titled "Sustained release of anti-infective aminoglycosides," covers formulations of aminoglycosides, including amikacin, with Insmed's liposomal delivery platform, formulation methods, … [Read more...] about Insmed gets European patent for Arikace

Elan Corporation has announced that it will pay Theravance $1 billion for a 21% participation interest in future royalty payments from sales of Breo (Relvar) Ellipta, Anoro Ellipta, MABA '081 bifunctional muscarinic antagonist-beta2 agonist monotherapy, and vilanterol monotherapy. Elan CEO Kelly Martin explained, “This transaction, upon closing, will immediately … [Read more...] about Elan makes billion dollar deal for inhaled drug royalites

Vectura has announced that it has partnered with Chinese pharmaceutical company Tianjin KingYork Group and Hong Kong private equity investor Zendex Bio Strategy to create Tianjin Kinnovata Pharmaceutical Company Limited ("Kinnovata"). The new company will develop, manufacture, and market inhaled drugs for asthma and COPD in Asia. Kinnovata will be an independent … [Read more...] about New joint venture in China to develop inhaled drugs